U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07187206) titled 'Safety and Efficacy of FETO in CDH Phase III' on Aug. 21.
Brief Summary: Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses and standard of care control group
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Congenital Diaphragmatic Hernia
Pulmonary Hypoplasia
Pulmonary Hypertension
Intervention:
DEVICE: FETO, Fetal Endoluminal Tracheal Occlusion
Fetal Endoluminal Tracheal Occlusion with Balloon placement for fetuses with congenital diaphragmatic hernia
Recruitment Status: RECRUITING
Sponsor: Children's Hospital Medical Center, Cincinnati
Published by HT Digital Content Serv...